About Brad Osborne
Form D filings for Melt Pharmaceuticals from 2023 to 2024 list Brad Osborne as chief financial officer.
Brad Osborne first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Brad Osborne in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Brad Osborne works with at each company, as listed on that company's latest Form D.
Melt Pharmaceuticals, Inc. · Form D/A, Apr 8, 2024
LD
Larry Dillaha
Executive officer and director